October 1, 2004

Risperidone Augmentation in the Treatment of Severe Adolescent OCD in SSRI-refractory Cases: A Case-series

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

These preliminary findings suggest that augmentation with risperidone in dosages up to 2 mg daily might be efficient in adolescents with treatment resistant OCD.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Per Hove Thomsen (Fri,) studied this question.

synapsesocial.com/papers/69ded0c47702a00918b0cdf9 https://doi.org/https://doi.org/10.1080/10401230490522016

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder1998 · 467 citations
2A Double-Blind Pilot Study of Risperidone in the Treatment of Conduct Disorder2000 · 312 citations
3Serotonin and Dopamine Antagonism in Obsessive-Compulsive Disorder: Effect of Atypical Antipsychotic Drugs2000 · 74 citations
4Combined SSRI-moclobemide treatment of psychiatric illness.1994 · 124 citations
5Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.1995 · 131 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo